EagleClaw Capital Managment, LLC
Source: SEC Form 13F · as of Mar 2026EagleClaw Capital Managment, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $47.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$47.1M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 72,234 | $15.7M |
| JNJJOHNSON & JOHNSON | 22,358 | $5.5M |
| NVSNovartis AG | 26,836 | $4.1M |
| MRKMerck & Co., Inc. | 31,638 | $3.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 7,385 | $3.3M |
| PFEPFIZER INC | 111,043 | $3.1M |
| SNYSanofi | 50,835 | $2.4M |
| NVONovo Nordisk A/S | 64,200 | $2.4M |
| BMYBRISTOL MYERS SQUIBB CO | 36,693 | $2.2M |
| LLYELI LILLY & Co | 1,797 | $1.7M |
| GILDGILEAD SCIENCES, INC. | 9,190 | $1.3M |
| AMGNAMGEN INC | 2,100 | $739K |
| ABTABBOTT LABORATORIES | 4,648 | $477K |
| MCKMcKesson Corporation | 455 | $394K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.